Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rigel Pharmaceuticals Affirms FY2025 Sales Guidance of $200.00M-$210.00M vs $228.79M Est

Author: Benzinga Newsdesk | May 06, 2025 04:44pm
Rigel Pharmaceuticals (NASDAQ:RIGL) affirms FY2025 sales outlook from $200.00 million-$210.00 million to $200.00 million-$210.00 million vs $228.79 million estimate.

Posted In: RIGL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist